Methotrexate is not associated with progression of interstitial lung disease in rheumatoid arthritis.
Gaffo
Angelo L
AL
Division of Clinical Immunology and Rheumatology, Department of Medicine/Rheumatology, University of Alabama at Birmingham, 510 20th St S, Faculty Office Tower, Room 830, Birmingham, AL 35294-3408. graciela.alarcon@ccc.uab.edu.
Alarcón
Graciela S
GS
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000503:physiopathology*; D008727:Methotrexate / Q000009:adverse effects*
D018501:Antirheumatic Agents; D008727:Methotrexate